QuarterHawk — Equity ResearchQuarterHawk — Equity Research

Healthcare Services Group, Inc. (HCSG)

Healthcare

Actionable
Fundamental
3
Sentiment
3
Technical
3

Bullish pullback_to_support: buy limit 23.85 at the EMA21 23.83 / SMA20 23.48 confluence within an intact uptrend (price above SMA20/50/200, MACD 1.02 above signal 0.91 above zero), protective stop 22.89 at the 1.0×ATR pullback floor beneath the 2026-10-28 swing low 23.80, targets 25.77 (T1 = +2.0×ATR14) and 27.21 (T2 = +3.5×ATR14), R/R 2.00, GTC; every Step 00 gate passed (price ≤ $25, fundamental 3 / qualitative 3, max overnight gap 2.44% ≤ 5%, recent 3-session liquidity ≈ $15.5M ≥ $1.5M, indicators loaded, fresh 2026-11-06 bars, ATR14 3.95% ≥ 1.0%, no events through horizon 2026-11-30).

Analysis as of 2026-11-06· more than 2 trading days ago

Company overview

Healthcare Services Group, Inc. provides outsourced management and operational services to healthcare and senior living facilities across the U.S. The company specializes in housekeeping, laundry, facility maintenance, and dietary services for nursing homes, hospitals, and rehabilitation centers. As of December 2021, it served approximately 3,000 facilities nationwide.

Fundamental

fair
Fundamental3
Mixed but improving

The company shows a strong balance sheet and improved margins, but faces thin gross margins and credit risks.

Mixed but improving fundamentals: a net-cash balance sheet, ~6.8% trailing free-cash-flow yield, double-digit ROE and sharply expanding 2026 margins sit against a structurally thin ~16% gross margin, a customer base exposed to Medicare/Medicaid reimbursement and repeated large bad-debt charges, and a valuation that is only fair on the recovery run-rate while standard DCF models imply downside. Regulatory disclosures are clean - no going-concern doubt, no covenant issues, unqualified audit.

Sentiment

fair
Sentiment3
Stable sentiment

Recent earnings beats and guidance raises have been absorbed, with no immediate catalysts ahead.

The dominant driver is the 2026-10-21 Q3 2026 print (EPS $0.36 vs $0.22 consensus) plus a 2027 revenue-growth outlook raise to low double digits (announced), which the tape rewarded into a 52-week high of $25.75 before a partial pullback to $24.28; media polarity is a determinate improvement, roughly +0.07 in the 30-90 day baseline versus +0.28 in the last 14 days (19 and 16 items scored). The Red-Flag Screen is clean, with no severe or moderate flag fired, but the rewarded catalyst is trailing and already largely absorbed with no forward-dated driver inside 30 days and no retail signal, which holds the setup in the forming/priced-in band rather than the top band.

Technical

fair
Technical3
Pullback to support

The stock is in a pullback within an uptrend, with technical indicators supporting a potential entry.

Medium/long-term trend is intact — price 24.28 sits above SMA20 23.48, SMA50 22.23, SMA200 21.56 and EMA21 23.83 — after a post-earnings run from 20.30 (2026-10-21 low) to 27.05 (2026-11-05 high). The last two sessions reversed hard (−8.4% from the high, closing on the session low both days), pushing price under the short-term stack (EMA9 24.83, WMA9 25.16, DEMA14 25.54, TEMA14 25.75) and under the daily VWAP 24.555, while RSI14 cooled from 81.7 (2026-10-23) to 55.2 and the MACD histogram contracted from 0.35 to 0.11. That is a pullback into support rather than a trend break: MACD line 1.02 still above signal 0.91 above zero, ADX14 23.5 and rising from 19.4 with price above every major average. A limit at 23.85 buys the first test of the EMA21 23.83 / SMA20 23.48 confluence; the Change-A floored stop 22.89 (1.0×ATR0.96) sits under the 2026-10-28 swing low 23.80 and yields R/R 2.00 against ATR targets 25.77/27.21.

You’re looking at 2026-11-06 — more than 2 trading days ago.

Subscribers saw this then, and see today’s score, verdict and trade plan now.

Not financial advice. For informational and educational purposes only.